This CME Activity offers a practical review of breast pathology combining basic to advanced techniques, pearls and pitfalls to pathologic diagnosis and case reviews.

This CME activity is primarily intended and designed to educate pathologists.

Educational Objectives 

At the completion of this CME activity, subscribers should be able to:

- Explain the spectrum of benign spindle cell lesions in the breast.
- Describe sclerosing lesions of the breast.
- Identify key features of genomic testing in breast cancer diagnosis and treatment planning.
- Discuss breast cancer predictive factor testing (ER, PR & HER2).
- Describe the diagnostic features and clinical significance of a variety of breast lesions with particular reference to the implications of these diagnoses in core needle biopsy specimens.

Topics/Speakers: 

Ductal Carcinoma In Situ of Breast: Updates and Differential Diagnoses
Charles D. Sturgis, M.D.

Spindle Cell and Vascular Lesions of Breast
Christopher D.M. Fletcher, M.D., FRCPath

Benign Breast Disease: Atypical Proliferative Lesion: Diagnosis and Breast Cancer Risk
David G. Hicks, M.D.

Sclerosing Lesions of the Breast
David G. Hicks, M.D.

Genomic in Breast Cancer Diagnosis and Treatment Planning: Is this an Opportunity to Enhance the Role of Pathologists in Multidisciplinary Care?
David G. Hicks, M.D.

Breast Cancer Predictive Factor Testing (ER, PR & HER2): Bridging the Gap Between Diagnosis and Management
David G. Hicks, M.D.

Ancillary Breast Cancer Studies: Rogue Cases, Challenges, Pitfalls and Trouble Shooting
David G. Hicks, M.D.

Challenging Breast Pathology Case Studies
David G. Hicks, M.D.

CME Release Date 1/14/2021

CME Expiration Date 1/14/2024